Medical artificial intelligence (AI) corporations Coreline Soft said on the 23rd that it has introduced the AI chest diagnosis platform "AVIEW LCS Plus" to the "GC&Phenikaa Healthcare Center," which opened in Hanoi, Vietnam.
GC&Phenikaa Healthcare Center is a premium health screening center established as a joint venture between GC Biopharma and Vietnam's Phenikaa group.
With this contract, Coreline Soft will supply its AI medical devices to an overseas screening center following GC Biopharma's Gangnam and Gangbuk centers in Korea.
AVIEW LCS Plus is an integrated solution that can simultaneously analyze pulmonary nodules, emphysema, and coronary artery calcification with a single low-dose chest CT scan. It provides automated lesion detection and quantification, along with a 3D visualization report.
Through this, the screening center has built a screening environment that precisely diagnoses major chest diseases while minimizing radiation exposure. Yang Song-hyeon, head of GC&Phenikaa Healthcare Center, said, "We have implemented an AI precision screening service in Vietnam that is on par with that in Korea."
Kim Jin-guk, head of Coreline Soft, said, "We will continue to contribute to the spread of AI early screening in partnership with global partners."